Validation of Naevia Medical in Valvulopathies

Inclusion Criteria: * Patients randomly selected from those presented during the year 2022 in medical-surgical sessions, with a primary diagnosis of: * aortic valve stenosis * aortic insufficiency * mitral valve stenosis * mitral insufficiency (greater than moderate severity).. * Patients randomly selected from valvulopathy clinic records attended during the year 2022, with a primary diagnosis of * aortic valve stenosis * aortic insufficiency * mitral valve stenosis * mitral insufficiency (greater than moderate severity) Exclusion Criteria: * Subjects under 18 years old. * Inability to anonymize the case. * Clinical cases of valvulopathies in which a complex congenital heart disease coexists. * Clinical cases that do not meet the minimum data set necessary for decision-making. * Clinical cases with a primary diagnosis other than valvulopathy. * Presence of bacterial endocarditis